Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
NeuroMetrix, Inc. NURO
$1.04
+$0.01 (1.43%)
На 18:01, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
8077490.00000000
-
week52high
5.89
-
week52low
0.97
-
Revenue
8256073
-
P/E TTM
-2
-
Beta
2.29584700
-
EPS
-0.63000000
-
Last Dividend
1728.00000000
-
Next Earnings Date
19 июл 2023 г. в 12:30
Описание компании
NeuroMetrix, Inc., a healthcare company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. Its primary marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system, a platform for the performance of nerve conduction studies. The company offers its products to managed care organizations, endocrinologists, podiatrists, and primary care physicians; occupational health, primary care, internal medicine, orthopedic, and hand surgeons; and pain medicine physicians, neurologists, physical medicine and rehabilitation physicians, and neurosurgeons. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Rodman & Renshaw | Buy | 25 ноя 2020 г. | |
| Rodman & Renshaw | Buy | 28 июн 2016 г. | |
| Dawson James | Buy | Buy | 30 апр 2012 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Fluegel Bradley M | A | 27472 | 27472 | 01 июл 2022 г. |
| Gozani Shai | A | 61029 | 61029 | 24 мая 2022 г. |
| HIGGINS THOMAS T | A | 47794 | 47794 | 24 мая 2022 г. |
| Goodman David | A | 17647 | 17647 | 24 мая 2022 г. |
| KATZ NANCY E | A | 17647 | 17647 | 24 мая 2022 г. |
| Van Avermaete David | A | 17647 | 17647 | 24 мая 2022 г. |
| HIGGINS THOMAS T | A | 39068 | 17059 | 15 апр 2022 г. |
| Gozani Shai | A | 51520 | 26890 | 15 апр 2022 г. |
| HIGGINS THOMAS T | D | 22009 | 1825 | 31 дек 2021 г. |
| HIGGINS THOMAS T | A | 23834 | 175 | 30 сент 2021 г. |
Новостная лента
NeuroMetrix, Inc. (NURO) Q1 2023 Earnings Call Transcript
Seeking Alpha
03 мая 2023 г. в 12:41
NeuroMetrix, Inc. (NASDAQ:NURO ) Q1 2023 Earnings Conference Call May 3, 2023 8:00 AM ET Company Participants Thomas Higgins - SVP, CFO & Treasurer Shai Gozani - Founder, Chairman, CEO, President & Secretary Conference Call Participants Operator Good morning, and welcome to the NeuroMetrix First Quarter 2023 Earnings Call. My name is Levay, and I'll be your moderator on the call.
NeuroMetrix, Inc. Announces Date for First Quarter 2023 Financial Results Conference Call
GlobeNewsWire
28 апр 2023 г. в 09:21
WOBURN, Mass., April 28, 2023 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to issue its 2023 first quarter financial results before the opening of the market on May 3, 2023. The Company will host a conference call at 8:00 a.m., Eastern Time on May 3, 2023 to discuss its financial results as well as business developments affecting the Company.
NeuroMetrix, Inc. (NURO) Q4 2022 Earnings Call Transcript
Seeking Alpha
23 февр 2023 г. в 17:23
NeuroMetrix, Inc. (NASDAQ:NURO ) Q4 2022 Results Conference Call February 23, 2023 8:00 AM ET Company Participants Thomas Higgins - Senior VP, CFO & Treasurer Shai Gozani - Founder, Chairman, CEO, President & Secretary Conference Call Participants Jarrod Cohen - Cohen Operator Good morning, and welcome to the NeuroMetrix Fourth Quarter and Full Year 2022 Earnings Call. My name is Latanya, and I will be your moderator on the call.
NeuroMetrix, Inc. Announces Date for Fourth Quarter and Full Year 2022 Financial Results Conference Call
GlobeNewsWire
16 февр 2023 г. в 14:58
WOBURN, Mass., Feb. 16, 2023 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to issue its 2022 fourth quarter and year end financial results before the opening of the market on February 23, 2023. The Company will host a conference call at 8:00 a.m., Eastern Time on February 23, 2023 to discuss its financial results as well as business developments affecting the Company.
NeuroMetrix, Inc. (NURO) Q3 2022 Earnings Call Transcript
Seeking Alpha
20 окт 2022 г. в 09:32
NeuroMetrix, Inc. (NASDAQ:NURO ) Q3 2022 Earnings Conference Call October 20, 2022 8:00 AM ET Company Participants Thomas Higgins - SVP & CFO Shai Gozani - CEO Conference Call Participants Jarrod Cohen - JM Cohen & Company William Church - TGRA Capital Operator Good morning, and welcome to the NeuroMetrix Third Quarter 2022 Earnings Call. My name is Michelle and I will be your moderator on the call.